Literature DB >> 30097335

Association of body mass index and diastolic function in metabolically healthy obese with preserved ejection fraction.

Zach Rozenbaum1, Yan Topilsky2, Shafik Khoury2, David Pereg3, Michal Laufer-Perl2.   

Abstract

BACKGROUND: Small scale cohorts demonstrated an association between body mass index (BMI) and diastolic function in a metabolically healthy population. We aimed to characterize the relation between BMI and diastolic function in a relatively large cohort of metabolically healthy obese with preserved ejection fraction. METHODS AND
RESULTS: Echocardiograms of metabolically healthy patients between 2011 and 2016, who had no significant valvulopathies or atrial fibrillation, and had preserved ejection fraction, were retrospectively identified and analyzed. Metabolically healthy was defined as lack of known diabetes mellitus, hypertension, and hyperlipidemia. Patients were categorized into 4 groups according to BMI - normal BMI 18.5-25, overweight 25.01-30, obese 30.01-35, morbidly obese >35 kg/m2. The cohort consisted of 7057 individuals, 54.9% males, with a mean age 54 years. Patients in higher BMI groups more commonly demonstrated abnormalities in most echocardiographic parameters associated with diastolic dysfunction, including left atrial volume index>34 ml/m2, E/e'>14, e' lateral<10 cm/s, e' septal<7 cm/s, tricuspid regurgitation velocity>2.8 m/s and systolic pulmonary artery pressure≥36 mmHg (p<0.01 for all comparisons). Morbidly obese carried the highest risk compared to those with normal BMI. There were no significant differences between the groups in rates of readmission due to heart failure.
CONCLUSION: High BMI is associated with increased risk of diastolic dysfunction even in metabolically healthy patients. Additional trials are needed in order to evaluate whether these echocardiographic findings translate into clinical implications.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BMI; Diastolic dysfunction; HFpEF; Metabolically healthy; Obesity

Mesh:

Year:  2018        PMID: 30097335     DOI: 10.1016/j.ijcard.2018.08.008

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

Review 1.  Obesity and heart failure with preserved ejection fraction: a paradox or something else?

Authors:  Marijana Tadic; Cesare Cuspidi
Journal:  Heart Fail Rev       Date:  2019-05       Impact factor: 4.214

Review 2.  The Role of Mitochondria in Metabolic Syndrome-Associated Cardiomyopathy.

Authors:  Jiayu Li; Jingye Li; Yijun Chen; Wenyu Hu; Xuhe Gong; Hui Qiu; Hui Chen; Yanguo Xin; Hongwei Li
Journal:  Oxid Med Cell Longev       Date:  2022-06-23       Impact factor: 7.310

Review 3.  Understanding Obesity-Related High Output Heart Failure and Its Implications.

Authors:  Qiuhua Shen; John B Hiebert; Faith K Rahman; Kathryn J Krueger; Bhanu Gupta; Janet D Pierce
Journal:  Int J Heart Fail       Date:  2021-01-13

4.  MicroRNA profiles in plasma samples from young metabolically healthy obese patients and miRNA-21 are associated with diastolic dysfunction via TGF-β1/Smad pathway.

Authors:  Pengkang Yang; Xin Dong; Yuyang Zhang
Journal:  J Clin Lab Anal       Date:  2020-02-28       Impact factor: 2.352

5.  Left ventricular strain values using 3D speckle-tracking echocardiography in healthy adults aged 20 to 72 years.

Authors:  Ferit Onur Mutluer; Daniel J Bowen; Roderick W J van Grootel; Jolien W Roos-Hesselink; Annemien E Van den Bosch
Journal:  Int J Cardiovasc Imaging       Date:  2020-11-23       Impact factor: 2.357

6.  Prevalence of obesity and its association with cardiometabolic risk factors, heart failure phenotype and mortality among patients hospitalized for heart failure in Egypt.

Authors:  Ahmed Hassanin; Mahmoud Hassanein; Gregg M Lanier; Mohamed Sadaka; Mohamed Rifaat; Mohamed Sanhoury
Journal:  Egypt Heart J       Date:  2022-01-03

7.  Interrelationship between micronutrients and cardiovascular structure and function in type 2 diabetes.

Authors:  Grace W M Walters; Emma Redman; Gaurav S Gulsin; Joseph Henson; Stavroula Argyridou; Thomas Yates; Melanie J Davies; Kelly Parke; Gerry P McCann; Emer M Brady
Journal:  J Nutr Sci       Date:  2021-10-04

8.  Repository Describing the Anatomical, Physiological, and Biological Changes in an Obese Population to Inform Physiologically Based Pharmacokinetic Models.

Authors:  Mattia Berton; Sara Bettonte; Felix Stader; Manuel Battegay; Catia Marzolini
Journal:  Clin Pharmacokinet       Date:  2022-06-14       Impact factor: 5.577

9.  Sex Differences in the Association of Cumulative Body Mass Index from Early Adulthood to Middle Age and Left Atrial Remodeling Evaluated by Three-Dimensional Echocardiography: The Coronary Artery Risk Development in Young Adults Study.

Authors:  Henrique Doria de Vasconcellos; Aisha Betoko; Luisa A Ciuffo; Henrique T Moreira; Chike C Nwabuo; Bharath Ambale-Venkatesh; Jared P Reis; Norrina Allen; Donald M Lloyd-Jones; Laura A Colangelo; Pamela J Schreiner; Cora E Lewis; James M Shikany; Stephen Sidney; Christopher Cox; Samuel S Gidding; Joao A C Lima
Journal:  J Am Soc Echocardiogr       Date:  2020-04-24       Impact factor: 5.251

10.  Hospitalization for heart failure incidence according to the transition in metabolic health and obesity status: a nationwide population-based study.

Authors:  You-Bin Lee; Da Hye Kim; Seon Mee Kim; Nan Hee Kim; Kyung Mook Choi; Sei Hyun Baik; Yong Gyu Park; Kyungdo Han; Hye Jin Yoo
Journal:  Cardiovasc Diabetol       Date:  2020-06-13       Impact factor: 9.951

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.